ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.

Andere talen Zhejiang Hisoar Pharmaceutical Co., Ltd.

Aandelen

002099

CNE000001PY2

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 06-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,44 ^CNY	+1,58%		+3,21%	-10,43%

28/04	Zhejiang Hisoar Pharmaceutical Co, Ltd. Rapporteert winstresultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
02/02	Zhejiang Hisoar Pharmaceutical Co, Ltd. (SZSE:002099) kondigt een aandeleninkoop aan voor CNY 30 miljoen aan aandelen.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	28/04
Hisoar Pharma's Unit Passes German Health Regulator's Inspection	18/04
Tranche Update on Zhejiang Hisoar Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	01/04
Zhejiang Hisoar Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 300 million worth of its shares.	02/02
Hisoar Pharma Chairman Plans Up to 20 Million Yuan Investment	02/02
Zhejiang Hisoar Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	02/02
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30-10-23
Zhejiang Hisoar Pharma Passes Good Manufacturing Practice Compliance Inspection	22-09-23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
Zhejiang Hisoar Pharma Registers New Drug For Diabetes Patients	11-07-23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 24 May 2023	19-05-23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Approves the Profit Distribution Proposal for 2022	16-05-23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces the Profit Distribution Proposal for 2022	25-04-23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24-04-23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24-04-23
Zhejiang Hisoar Pharmaceutical Co., Ltd. Elects Tao Hong as Non-Independent Director; and Yu Yongping, Qian Jianmin and Liang Chao as Independent Directors	01-12-22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30-10-22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22
Hainan Visum Pharmaceutical Co Ltd announced that it has received $15 million in funding from Zhejiang Hisoar Pharmaceutical Co., Ltd.	29-06-22
Zhejiang Hisoar Pharmaceutical Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 25 May 2022	18-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Zhejiang Hisoar Pharmaceutical Co., Ltd.

Aandelen

002099

CNE000001PY2

Andere talen

Filters